Can a tablet game sharpen aging minds during breast cancer treatment?

NCT ID NCT04261153

Completed Symptom relief Sponsor: Centre Francois Baclesse Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study explores whether a tablet-based cognitive stimulation program called HAPPYNeuron® is practical for breast cancer patients aged 70 and older. Cancer treatments, especially chemotherapy, can cause memory and thinking problems, and older patients may be at higher risk. The study will have participants complete three 20-minute sessions on a tablet to see if they can and will use the software, aiming to find a way to help reduce cognitive side effects and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HAPPYNeuron® cognitive stimulation software
What this could lead to: If successful, this could point toward a practical, non-drug way to help older breast cancer patients maintain memory and thinking skills during cancer treatment.
What could go wrong: This is a small feasibility study, so it cannot prove the software improves cognition. Older patients may find tablet use difficult, and the program may not be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Centre François Baclesse

Caen, 14076, France
Centre Henri Becquerel

Rouen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.